Volume 24, Issue 4 pp. 446-448
Case Report

Vasovagal syncope and severe bradycardia following intranasal dexmedetomidine for pediatric procedural sedation

Vinit J. Patel

Corresponding Author

Vinit J. Patel

Section of Pediatric Critical Care, Department of Pediatrics, Indiana University School of Medicine, Riley Hospital for Children at Indiana University Health, Indianapolis, IN, USA

Correspondence

V. Patel, Section of Pediatric Critical Care, Riley Hospital for Children at Indiana University Health, 705 Riley Hospital Drive R2117, Indianapolis, IN 46202, USA

Email: [email protected]

Search for more papers by this author
Sheikh S. Ahmed

Sheikh S. Ahmed

Section of Pediatric Critical Care, Department of Pediatrics, Indiana University School of Medicine, Riley Hospital for Children at Indiana University Health, Indianapolis, IN, USA

Search for more papers by this author
Mara E. Nitu

Mara E. Nitu

Section of Pediatric Critical Care, Department of Pediatrics, Indiana University School of Medicine, Riley Hospital for Children at Indiana University Health, Indianapolis, IN, USA

Search for more papers by this author
Mark R. Rigby

Mark R. Rigby

Section of Pediatric Critical Care, Department of Pediatrics, Indiana University School of Medicine, Riley Hospital for Children at Indiana University Health, Indianapolis, IN, USA

Search for more papers by this author
First published: 26 February 2014
Citations: 16

Summary

We report syncope and bradycardia in an 11-year-old girl following administration of intranasal dexmedetomidine for sedation for a voiding cystourethrogram. Following successful completion of VCUG and a 60-min recovery period, the patient's level of consciousness and vital signs returned to presedation levels. Upon leaving the sedation area, the patient collapsed, with no apparent inciting event. The patient quickly regained consciousness and no injury occurred. The primary abnormality found was persistent bradycardia, and she was admitted to the hospital for telemetric observation. The bradycardia lasted ~2 h, and further cardiac workup revealed no underlying abnormality. Unanticipated and previously unreported outcomes may be witnessed as we expand the use of certain sedatives to alternative routes of administration.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.